多抗药性败血症:一个关键的医疗保健挑战
Nishitha R Kumar1, Tejashree A Balraj2, Swetha N Kempegowda1
1Department of Biochemistry, JSS Medical College and Hospital, JSS Academy of Higher Education & Research, Mysuru 570004, India.
Antibiotics (Basel, Switzerland)
|January 22, 2024
概括
耐多药性败血症是一个关键的全球卫生问题. 创新的诊断和量身定制的治疗对于管理这种复杂的疾病和降低高死亡率至关重要.
科学领域:
- 传染性疾病 传染性疾病
- 关键护理医学 关键护理医学
- 公共卫生 公共卫生
背景情况:
- 败血症在全球造成数百万人的死亡,并对经济产生重大影响.
- 耐多药生物 (MDROs) 加剧败血症,创造了一个关键的全球卫生挑战.
- 重症患者面临复杂的病理生理学和免疫反应,阻碍了败血症治疗.
研究的目的:
- 审查多抗药性 (MDR) 败血症的流行病学.
- 概述关键病患者的相关医疗保健挑战.
- 探索目前和未来的MDR败血症的管理策略.
主要方法:
- 关于当前流行病学和挑战的综合文献综述.
- 分析导致复发性败血症和死亡率的因素.
- 对诊断创新和治疗干预措施的评估.
主要成果:
- 衰老,滥用抗生素和并发症增加了复发性败血症的风险,导致严重的后果.
- 升高的再接收率与认知和器官功能障碍相关,增加成本.
- 护理点检测 (POCT) 是有前途的,但需要进一步开发耐药性生物标志物检测.
结论:
- 治疗MDR败血症需要创新的诊断和个性化的治疗方法.
- 组合疗法和精准医学为MDR败血症治疗提供了新的途径.
- 针对当地耐药性模式的区域战略对于有效的败血症控制至关重要.
相关概念视频
Healthcare Associated Infections II: Preventive Measures
2.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.6K
Pulmonary Tuberculosis V
180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Pneumonia IV: Management
331
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
331
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Antibiotic Selection
53.7K
Overview
53.7K


